| Total Revenue | | 0 | 0 | 0 | |
| Cost of Goods Sold Incl. D&A | | 0 | 0 | 0 |
| Gross Profit | | 0 | 0 | 0 |
| Selling, General and Administrative Excl. Other | | 48 | 49 | 37 |
| Research and Development | | 345 | 102 | 64 |
| Other Operating Expense | | 0 | 0 | 0 |
| Operating Income | | -393 | -151 | -101 |
| Interest Expense | | 0 | 0 | 0 |
| Unusual Expense | | — | — | — |
| Non-Operating Income (Expense) | | -34 | -41 | -15 |
| Net Income Before Taxes | | -360 | -110 | -86 |
| Income Taxes | | 0 | 0 | 0 |
| Consolidated Net Income | | -360 | -110 | -86 |
| Net Income From Continuing Operations | | -360 | -110 | -86 |
| Net Income | | -360 | -110 | -86 |
| EPS (Recurring) | | -3.19 | -1.01 | -0.91 |
| EPS (Basic, Before Extraordinaries) | | -3.19 | -1.01 | -0.91 |
| EPS (Diluted) | | -3.19 | -1.01 | -0.91 |
| EBITDA | | -359 | -110 | -86 |
| Other After Tax Adjustments | | — | — | — |
| Stock Option Compensation Expense | | — | — | — |
| Price To Earnings Ratio | | — | — | — |
| Price To Sales Ratio | | — | — | — |
| Gross Margin | | — | — | — |
| Operating Margin | | — | — | — |
| Net Margin | | — | — | — |
| Shares Outstanding | | 113 | 109 | 94 |
| Market Capitalization | | 3,975 | — | — |
| Operating Lease Expense | | — | — | — |
